NSG 527 Midterm Exam Prep Document | 2026/2027 Edition |
250 Verified Questions
NSG 527 Midterm Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive practice test document is meticulously designed for graduate nursing students
preparing for the NSG 527 midterm and final exams. It features 250 verified questions with detailed
rationales, aligned with the course objectives. The content covers advanced nursing concepts,
evidence-based practice, and clinical decision-making. Each question is crafted to mirror the format
and difficulty of actual exams, ensuring thorough preparation. This edition is updated for the
2026/2027 academic year, reflecting the latest guidelines and best practices.
Key Features:
Advanced Pathophysiology and Pharmacology
Evidence-Based Practice and Research Integration
Clinical Reasoning and Decision-Making
Ethical and Legal Issues in Graduate Nursing
Health Promotion and Disease Prevention
Leadership and Healthcare Policy
Updates for 2026:
- Incorporated 2026-2027 clinical practice guidelines
- Revised rationales to reflect current evidence-based literature
- Added new questions on emerging healthcare technologies
- Aligned content with updated NSG 527 course objectives
- Enhanced answer explanations for deeper understanding
Abstract:
This exam preparation resource offers a rigorous and comprehensive review for graduate nursing students
enrolled in NSG 527. The document contains 250 verified practice questions that span the breadth of the course
curriculum, including advanced health assessment, pathophysiology, pharmacology, and evidence-based practice.
Each question is accompanied by a detailed rationale that explains the correct answer and distractor analysis,
facilitating a deeper comprehension of complex concepts. The content is structured to reinforce critical thinking
and clinical judgment, essential for success on the midterm and final exams. Updated for the 2026/2027 academic
year, this edition aligns with the latest evidence and professional standards. By engaging with these practice
questions, students will enhance their readiness and confidence for high-stakes assessments. This resource serves
as an invaluable tool for mastering the core competencies required in graduate nursing practice.
Keywords:
NSG 527, Midterm Exam, Final Exam, Graduate Nursing, Practice Questions, Detailed Rationales,
Evidence-Based Practice, 2026-2027
Answer Format:
Each question is followed by the correct answer and a comprehensive rationale that explains why it is correct,
along with an analysis of why the other options are incorrect. The rationales are written in a clear, scholarly style,
referencing current evidence and guidelines. This format ensures that students not only know the right answer but
also understand the underlying concepts and clinical reasoning.
Compliance Checklist:
Aligned with NSG 527 course objectives
Page 1
, Verified answers with evidence-based rationales
Updated to reflect 2026-2027 academic standards
Covers all major content areas of the course
Designed to simulate actual exam conditions
Suitable for self-assessment and review
Content Area Overview:
Content Area Questions Key Topics Weight
Advanced Health Assessment 1-50 Comprehensive history taking, physical 20%
examination techniques, diagnostic
reasoning
Pathophysiology 51-100 Cellular adaptation, inflammation, 20%
neoplasia, genetic disorders
Pharmacology 101-150 Pharmacokinetics, pharmacodynamics, drug 20%
interactions, adverse effects
Evidence-Based Practice 151-200 Research methods, critical appraisal, 20%
translating evidence into practice
Leadership and Ethics 201-250 Healthcare policy, ethical decision-making, 20%
interprofessional collaboration
Page 2
,Q1. A patient with type 2 diabetes and chronic kidney disease (eGFR 25 mL/min) is
prescribed metformin. Which adjustment is most appropriate?
A. Continue current dose; metformin is safe in CKD.
B. Reduce dose by 50% and monitor renal function.
C. Discontinue metformin; contraindicated at this eGFR.
D. Switch to insulin; metformin is ineffective in CKD.
Correct Answer: C. Discontinue metformin; contraindicated at this eGFR.
Rationale: Metformin is contraindicated when eGFR falls below 30 mL/min due to
increased risk of lactic acidosis. Current guidelines recommend discontinuing metformin
at eGFR <30 mL/min. Options A, B, and D are incorrect because they either ignore the
contraindication or suggest inappropriate alternatives.
Why Wrong:
A - Metformin is not safe at eGFR <30 due to lactic acidosis risk.
B - Dose reduction is only considered for eGFR 30-45, not below 30.
D - Insulin may be needed, but the immediate action is to stop metformin.
Reference: American Diabetes Association. (2026). Standards of Care in Diabetes-2026.
Diabetes Care, 49(Suppl 1).
Q2. In a patient with septic shock, which hemodynamic parameter best indicates the
need for additional vasopressor support despite adequate fluid resuscitation?
A. Central venous pressure (CVP) of 6 mmHg
B. Mean arterial pressure (MAP) of 58 mmHg
C. Urine output of 0.6 mL/kg/hr
D. Lactate level of 2.0 mmol/L
Correct Answer: B. Mean arterial pressure (MAP) of 58 mmHg
Rationale: MAP below 65 mmHg despite adequate fluid resuscitation indicates persistent
shock requiring vasopressor support. CVP is not a reliable indicator of fluid
responsiveness. Urine output and lactate may be abnormal but are not the primary criteria
for initiating vasopressors.
Why Wrong:
A - CVP is not a reliable indicator for vasopressor initiation.
C - Urine output reflects renal perfusion but is not the primary trigger.
D - Lactate is a marker of tissue hypoxia but not the immediate criterion for
vasopressors.
Reference: Surviving Sepsis Campaign. (2025). International Guidelines for Management
of Sepsis and Septic Shock.
Q3. A patient on warfarin has an INR of 5.2 without bleeding. Which intervention is
most appropriate?
Page 3
, A. Administer vitamin K 10 mg IV and hold warfarin.
B. Hold warfarin and give vitamin K 1-2 mg orally.
C. Administer fresh frozen plasma immediately.
D. Continue warfarin and recheck INR in 24 hours.
Correct Answer: B. Hold warfarin and give vitamin K 1-2 mg orally.
Rationale: For INR >4.5 without bleeding, guidelines recommend holding warfarin and
giving oral vitamin K (1-2 mg) to lower INR. IV vitamin K is for rapid reversal in
bleeding. FFP is for life-threatening bleeding. Continuing warfarin is unsafe.
Why Wrong:
A - IV vitamin K 10 mg is for major bleeding; oral low dose is preferred.
C - FFP is reserved for active bleeding or urgent surgery.
D - Continuing warfarin at INR >4.5 increases bleeding risk.
Reference: Douketis, J. D., et al. (2025). Antithrombotic therapy. Chest.
Q4. Which finding is most indicative of malignant hyperthermia during anesthesia?
A. Decreased end-tidal CO2 and bradycardia
B. Rapid rise in body temperature and muscle rigidity
C. Hypertension and tachycardia with fever
D. Hypocalcemia and hyperkalemia
Correct Answer: B. Rapid rise in body temperature and muscle rigidity
Rationale: Malignant hyperthermia presents with a rapid rise in temperature, muscle
rigidity (especially masseter spasm), and increased end-tidal CO2 due to
hypermetabolism. The other options do not capture the classic triad of hyperthermia,
rigidity, and hypercapnia.
Why Wrong:
A - ETCO2 is increased, not decreased, and heart rate is elevated.
C - Hypertension and tachycardia may occur but are not specific.
D - Hyperkalemia can occur but hypocalcemia is not typical.
Reference: Rosenberg, H., et al. (2025). Malignant hyperthermia. Anesthesiology.
Q5. A patient with heart failure with reduced ejection fraction (HFrEF) is on
sacubitril/valsartan. Which lab value requires immediate attention?
A. Potassium 5.5 mEq/L
B. BUN 25 mg/dL
C. Hemoglobin 12 g/dL
D. BNP 200 pg/mL
Correct Answer: A. Potassium 5.5 mEq/L
Page 4
250 Verified Questions
NSG 527 Midterm Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified
Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive practice test document is meticulously designed for graduate nursing students
preparing for the NSG 527 midterm and final exams. It features 250 verified questions with detailed
rationales, aligned with the course objectives. The content covers advanced nursing concepts,
evidence-based practice, and clinical decision-making. Each question is crafted to mirror the format
and difficulty of actual exams, ensuring thorough preparation. This edition is updated for the
2026/2027 academic year, reflecting the latest guidelines and best practices.
Key Features:
Advanced Pathophysiology and Pharmacology
Evidence-Based Practice and Research Integration
Clinical Reasoning and Decision-Making
Ethical and Legal Issues in Graduate Nursing
Health Promotion and Disease Prevention
Leadership and Healthcare Policy
Updates for 2026:
- Incorporated 2026-2027 clinical practice guidelines
- Revised rationales to reflect current evidence-based literature
- Added new questions on emerging healthcare technologies
- Aligned content with updated NSG 527 course objectives
- Enhanced answer explanations for deeper understanding
Abstract:
This exam preparation resource offers a rigorous and comprehensive review for graduate nursing students
enrolled in NSG 527. The document contains 250 verified practice questions that span the breadth of the course
curriculum, including advanced health assessment, pathophysiology, pharmacology, and evidence-based practice.
Each question is accompanied by a detailed rationale that explains the correct answer and distractor analysis,
facilitating a deeper comprehension of complex concepts. The content is structured to reinforce critical thinking
and clinical judgment, essential for success on the midterm and final exams. Updated for the 2026/2027 academic
year, this edition aligns with the latest evidence and professional standards. By engaging with these practice
questions, students will enhance their readiness and confidence for high-stakes assessments. This resource serves
as an invaluable tool for mastering the core competencies required in graduate nursing practice.
Keywords:
NSG 527, Midterm Exam, Final Exam, Graduate Nursing, Practice Questions, Detailed Rationales,
Evidence-Based Practice, 2026-2027
Answer Format:
Each question is followed by the correct answer and a comprehensive rationale that explains why it is correct,
along with an analysis of why the other options are incorrect. The rationales are written in a clear, scholarly style,
referencing current evidence and guidelines. This format ensures that students not only know the right answer but
also understand the underlying concepts and clinical reasoning.
Compliance Checklist:
Aligned with NSG 527 course objectives
Page 1
, Verified answers with evidence-based rationales
Updated to reflect 2026-2027 academic standards
Covers all major content areas of the course
Designed to simulate actual exam conditions
Suitable for self-assessment and review
Content Area Overview:
Content Area Questions Key Topics Weight
Advanced Health Assessment 1-50 Comprehensive history taking, physical 20%
examination techniques, diagnostic
reasoning
Pathophysiology 51-100 Cellular adaptation, inflammation, 20%
neoplasia, genetic disorders
Pharmacology 101-150 Pharmacokinetics, pharmacodynamics, drug 20%
interactions, adverse effects
Evidence-Based Practice 151-200 Research methods, critical appraisal, 20%
translating evidence into practice
Leadership and Ethics 201-250 Healthcare policy, ethical decision-making, 20%
interprofessional collaboration
Page 2
,Q1. A patient with type 2 diabetes and chronic kidney disease (eGFR 25 mL/min) is
prescribed metformin. Which adjustment is most appropriate?
A. Continue current dose; metformin is safe in CKD.
B. Reduce dose by 50% and monitor renal function.
C. Discontinue metformin; contraindicated at this eGFR.
D. Switch to insulin; metformin is ineffective in CKD.
Correct Answer: C. Discontinue metformin; contraindicated at this eGFR.
Rationale: Metformin is contraindicated when eGFR falls below 30 mL/min due to
increased risk of lactic acidosis. Current guidelines recommend discontinuing metformin
at eGFR <30 mL/min. Options A, B, and D are incorrect because they either ignore the
contraindication or suggest inappropriate alternatives.
Why Wrong:
A - Metformin is not safe at eGFR <30 due to lactic acidosis risk.
B - Dose reduction is only considered for eGFR 30-45, not below 30.
D - Insulin may be needed, but the immediate action is to stop metformin.
Reference: American Diabetes Association. (2026). Standards of Care in Diabetes-2026.
Diabetes Care, 49(Suppl 1).
Q2. In a patient with septic shock, which hemodynamic parameter best indicates the
need for additional vasopressor support despite adequate fluid resuscitation?
A. Central venous pressure (CVP) of 6 mmHg
B. Mean arterial pressure (MAP) of 58 mmHg
C. Urine output of 0.6 mL/kg/hr
D. Lactate level of 2.0 mmol/L
Correct Answer: B. Mean arterial pressure (MAP) of 58 mmHg
Rationale: MAP below 65 mmHg despite adequate fluid resuscitation indicates persistent
shock requiring vasopressor support. CVP is not a reliable indicator of fluid
responsiveness. Urine output and lactate may be abnormal but are not the primary criteria
for initiating vasopressors.
Why Wrong:
A - CVP is not a reliable indicator for vasopressor initiation.
C - Urine output reflects renal perfusion but is not the primary trigger.
D - Lactate is a marker of tissue hypoxia but not the immediate criterion for
vasopressors.
Reference: Surviving Sepsis Campaign. (2025). International Guidelines for Management
of Sepsis and Septic Shock.
Q3. A patient on warfarin has an INR of 5.2 without bleeding. Which intervention is
most appropriate?
Page 3
, A. Administer vitamin K 10 mg IV and hold warfarin.
B. Hold warfarin and give vitamin K 1-2 mg orally.
C. Administer fresh frozen plasma immediately.
D. Continue warfarin and recheck INR in 24 hours.
Correct Answer: B. Hold warfarin and give vitamin K 1-2 mg orally.
Rationale: For INR >4.5 without bleeding, guidelines recommend holding warfarin and
giving oral vitamin K (1-2 mg) to lower INR. IV vitamin K is for rapid reversal in
bleeding. FFP is for life-threatening bleeding. Continuing warfarin is unsafe.
Why Wrong:
A - IV vitamin K 10 mg is for major bleeding; oral low dose is preferred.
C - FFP is reserved for active bleeding or urgent surgery.
D - Continuing warfarin at INR >4.5 increases bleeding risk.
Reference: Douketis, J. D., et al. (2025). Antithrombotic therapy. Chest.
Q4. Which finding is most indicative of malignant hyperthermia during anesthesia?
A. Decreased end-tidal CO2 and bradycardia
B. Rapid rise in body temperature and muscle rigidity
C. Hypertension and tachycardia with fever
D. Hypocalcemia and hyperkalemia
Correct Answer: B. Rapid rise in body temperature and muscle rigidity
Rationale: Malignant hyperthermia presents with a rapid rise in temperature, muscle
rigidity (especially masseter spasm), and increased end-tidal CO2 due to
hypermetabolism. The other options do not capture the classic triad of hyperthermia,
rigidity, and hypercapnia.
Why Wrong:
A - ETCO2 is increased, not decreased, and heart rate is elevated.
C - Hypertension and tachycardia may occur but are not specific.
D - Hyperkalemia can occur but hypocalcemia is not typical.
Reference: Rosenberg, H., et al. (2025). Malignant hyperthermia. Anesthesiology.
Q5. A patient with heart failure with reduced ejection fraction (HFrEF) is on
sacubitril/valsartan. Which lab value requires immediate attention?
A. Potassium 5.5 mEq/L
B. BUN 25 mg/dL
C. Hemoglobin 12 g/dL
D. BNP 200 pg/mL
Correct Answer: A. Potassium 5.5 mEq/L
Page 4
